Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

Krista F.g. Huybrechts, Ph.D.

Co-Author

This page shows the publications co-authored by Krista Huybrechts and Rishi Desai.
Connection Strength

5.973
  1. A Propensity-score-based Fine Stratification Approach for Confounding Adjustment When Exposure Is Infrequent. Epidemiology. 2017 03; 28(2):249-257.
    View in: PubMed
    Score: 0.748
  2. In Reply: Cho et al. Obstet Gynecol. 2014 Sep; 124(3):638.
    View in: PubMed
    Score: 0.629
  3. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol. 2014 May; 123(5):997-1002.
    View in: PubMed
    Score: 0.614
  4. Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study. BMJ. 2021 02 10; 372:n102.
    View in: PubMed
    Score: 0.246
  5. The Patterns of Use of Medications for Inflammatory Bowel Disease During Pregnancy in the US and Sweden Are Changing. Inflamm Bowel Dis. 2020 Nov 18.
    View in: PubMed
    Score: 0.242
  6. Hydroxychloroquine early in pregnancy and risk of birth defects. Am J Obstet Gynecol. 2021 03; 224(3):290.e1-290.e22.
    View in: PubMed
    Score: 0.239
  7. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring. JAMA. 2018 12 18; 320(23):2429-2437.
    View in: PubMed
    Score: 0.212
  8. Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. Am J Psychiatry. 2018 06 01; 175(6):564-574.
    View in: PubMed
    Score: 0.203
  9. Placental Complications Associated With Psychostimulant Use in Pregnancy. Obstet Gynecol. 2017 12; 130(6):1192-1201.
    View in: PubMed
    Score: 0.197
  10. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study. BMJ. 2017 Aug 02; 358:j3326.
    View in: PubMed
    Score: 0.193
  11. The Potential Return on Public Investment in Detecting Adverse Drug Effects. Med Care. 2017 06; 55(6):545-551.
    View in: PubMed
    Score: 0.190
  12. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ. 2017 Mar 06; 356:j895.
    View in: PubMed
    Score: 0.187
  13. Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations. Obstet Gynecol. 2017 01; 129(1):174-184.
    View in: PubMed
    Score: 0.185
  14. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA Psychiatry. 2016 09 01; 73(9):938-46.
    View in: PubMed
    Score: 0.181
  15. Late Pregnancy ß Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia. Pediatrics. 2016 09; 138(3).
    View in: PubMed
    Score: 0.181
  16. Brief Report: Patterns and Secular Trends in Use of Immunomodulatory Agents During Pregnancy in Women With Rheumatic Conditions. Arthritis Rheumatol. 2016 05; 68(5):1183-9.
    View in: PubMed
    Score: 0.176
  17. Suppression of Substance Abuse Claims in Medicaid Data and Rates of Diagnoses for Non-Substance Abuse Conditions. JAMA. 2016 Mar 15; 315(11):1164-6.
    View in: PubMed
    Score: 0.175
  18. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA. 2015 Jun 02; 313(21):2142-51.
    View in: PubMed
    Score: 0.166
  19. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 2015 May 14; 350:h2102.
    View in: PubMed
    Score: 0.165
  20. Statins and congenital malformations: cohort study. BMJ. 2015 Mar 17; 350:h1035.
    View in: PubMed
    Score: 0.163
  21. Chronic prescription opioid use in pregnancy in the United States. Pharmacoepidemiol Drug Saf. 2021 Apr; 30(4):504-513.
    View in: PubMed
    Score: 0.061
  22. Prescription opioid use after vaginal delivery and subsequent persistent opioid use and misuse. Am J Obstet Gynecol MFM. 2021 03; 3(2):100304.
    View in: PubMed
    Score: 0.061
  23. Predicting overdose among individuals prescribed opioids using routinely collected healthcare utilization data. PLoS One. 2020; 15(10):e0241083.
    View in: PubMed
    Score: 0.060
  24. Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: A population-based cohort study nested in the US Medicaid Analytic eXtract dataset. PLoS Med. 2020 09; 17(9):e1003322.
    View in: PubMed
    Score: 0.060
  25. Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes. J Clin Psychiatry. 2019 06 18; 80(4).
    View in: PubMed
    Score: 0.055
  26. Anticonvulsants and the risk of perinatal bleeding complications: A pregnancy cohort study. Neurology. 2018 08 07; 91(6):e533-e542.
    View in: PubMed
    Score: 0.051
  27. Using prescription claims to detect aberrant behaviors with opioids: comparison and validation of 5 algorithms. Pharmacoepidemiol Drug Saf. 2019 01; 28(1):62-69.
    View in: PubMed
    Score: 0.051
  28. Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study. Neurology. 2018 01 23; 90(4):e342-e351.
    View in: PubMed
    Score: 0.049
  29. Patterns of opioid initiation at first visits for pain in United States primary care settings. Pharmacoepidemiol Drug Saf. 2018 05; 27(5):495-503.
    View in: PubMed
    Score: 0.049
  30. Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States. Psychiatr Serv. 2017 Nov 01; 68(11):1112-1119.
    View in: PubMed
    Score: 0.048
  31. Lithium Use in Pregnancy and the Risk of Cardiac Malformations. N Engl J Med. 2017 06 08; 376(23):2245-2254.
    View in: PubMed
    Score: 0.048
  32. Pregabalin use early in pregnancy and the risk of major congenital malformations. Neurology. 2017 May 23; 88(21):2020-2025.
    View in: PubMed
    Score: 0.047
  33. Calcium Channel Blocker Exposure in Late Pregnancy and the Risk of Neonatal Seizures. Obstet Gynecol. 2015 Aug; 126(2):271-278.
    View in: PubMed
    Score: 0.042
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.